GlassScriptPhysician profile
Hugo Escobar
NPI 1659531846
$1,557.79
in general payments reported to CMS, 2019-2025
20 companies · $407 in 2025
The $407 reported for 2025 was more than what 75% of Pediatric Pulmonology providers received nationally (typical 2025 total: $140).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $345 · 2020: $19.64 · 2021: $137 · 2022: $14.31 · 2023: $303 · 2024: $332 · 2025: $407.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $973 · Education: $69.52.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $972.55 |
| Education | $69.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $439.21 | 2019-2024 | Tezspire |
| Amgen INC. | $218.91 | 2023-2025 | Tezspire |
| Insmed, INC. | $161.02 | 2025 | Arikayce, Brinsupri |
| Biogen, INC. | $115.46 | 2019 | |
| Mylan Specialty L.P. | $107.22 | 2019-2024 | Tobi Podhaler |
| Abbvie INC. | $103.80 | 2019-2025 | |
| Viatris Specialty LLC | $100.93 | 2025 | Tobi Podhaler |
| Vertex Pharmaceuticals Incorporated | $90.44 | 2019-2025 | Trikafta |
| Baxter Healthcare | $37.02 | 2024 | Hillrom - Vest System Model 105 Home Care |
| Regeneron Healthcare Solutions, INC. | $26.40 | 2019 | |
| Olympus America INC. | $22.26 | 2025 | |
| Allergan, INC. | $19.64 | 2020 | |
| Glaxosmithkline, LLC. | $19.63 | 2019 | |
| Chiesi USA, INC. | $19.50 | 2021 | |
| Aimmune Therapeutics, INC. | $17.81 | 2024 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $17.41 | 2019 | |
| Alcresta Therapeutics, INC. | $14.76 | 2023 | Relizorb |
| Electromed, INC. | $14.00 | 2024 | Smartvest |
| Advanced Respiratory, INC | $12.37 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hugo Escobar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.